Bayer settles with 30 states over Baycol marketing

Share this article:
Bayer has reached a settlement with 30 states to resolve a consumer protection enforcement action over the marketing of Baycol, a cholesterol-lowering drug withdrawn from the market in 2001. The states will share $8 million as part of the judgment.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Channel

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.